Multinodular Goiter

Slide 1 · Multinodular Goiter

Pathogenesis • morphology • clinicopathologic interpretation

Follicular nodular disease

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

By the end of the lecture, interpret the disease from mechanism through morphology to clinical assessment.

Distinguish diffuse goiter, multinodular goiter and follicular adenoma.

Explain repeated hyperplasia–involution and nodular autonomy.

Recognize gross and microscopic patterns and degenerative change.

Relate size, location, function and suspicious nodules to clinical consequences.

Slide 3 · Core definition: Irregular nodular enlargement

Multinodular goiter arises after repeated episodes of follicular hyperplasia and involution.

Growth becomes regionally uneven rather than diffusely symmetric.

The gland contains multiple variably sized and active follicular regions.

The morphologic term is follicular nodular disease.

Trachea

Schematic

Slide 4 · Thyroid size does not define function

Goiter may occur in euthyroid, hypothyroid or hyperthyroid states.

Enlargement

Diffuse or multinodular

Variable gland volume

Mass effect depends on location

Functional state

Euthyroid is common

Hypothyroidism may occur

Hyperthyroidism in toxic disease

Slide 5 · TSH drives compensatory thyroid enlargement

Reduced thyroid-hormone production can increase pituitary TSH stimulation.

Falling hormone output increases trophic drive to follicular epithelium.

Follicular hypertrophy and hyperplasia expand functional gland mass.

This response can restore hormone output despite persistent stimulation.

Reduced hormone synthesis

Compensatory TSH increase

Follicular hypertrophy + hyperplasia

Expanded functional mass

Slide 6 · Why many enlarged glands remain euthyroid

Functional compensation and morphologic enlargement are not contradictory.

The growing gland may overcome an earlier hormone deficit.

Thyroid function can be preserved after enlargement becomes established.

The biochemical state must be assessed independently from gland size.

Large gland ≠ hyperthyroidism

Structural enlargement can coexist with preserved thyroid hormone production.

Slide 7 · When compensation does not suffice

Severe iodine deficiency or congenital biosynthetic defects may produce goitrous hypothyroidism.

Impaired synthesis persists despite increased follicular mass.

The stimulus can drive growth without restoring adequate output.

This is a parent-context mechanism—not the required state of every multinodular goiter.

Severe biosynthetic limitation

Compensatory growth

Persistent low hormone output

Slide 8 · Simple diffuse goiter: Hyperplastic phase

The earliest compensatory response is commonly diffuse and relatively symmetric.

The gland enlarges, usually far less markedly than advanced multinodular goiter.

Epithelial cells become crowded and columnar.

Some follicular linings project into the lumen during active stimulation.

Illustrative follicle patterns — schematic

Slide 9 · Uneven follicular response begins early

Even diffuse hyperplasia is not morphologically uniform.

Some follicles become distended while neighboring follicles remain small.

Regional differences create an early substrate for later irregular growth.

This heterogeneity helps explain why repeated cycles do not produce identical nodules.

Illustrative follicle patterns — schematic

Slide 10 · Involution follows reduced trophic demand

Increased iodine availability or reduced hormonal demand may reverse follicular activation.

Follicular epithelium becomes low cuboidal or flattened.

Colloid accumulates within enlarged follicles.

The gland becomes relatively inactive and colloid rich.

Reduced stimulation

Epithelial involution

Colloid accumulation

Enlarged colloid-rich follicles

Slide 11 · Hyperplasia and involution leave different signatures

Epithelial height and colloid content reflect different functional phases.

Hyperplastic phase

Active follicular proliferation

Crowded / taller cells

Variable luminal projections

Colloid involution

Flattened / low cells

Enlarged colloid stores

Increased follicle size

Slide 12 · Repeated cycles yield the nodular gland

Temporal repetition converts diffuse enlargement into a nonuniform organ.

Follicular regions do not grow or regress identically.

Repeated activation and involution establish nodules of differing size.

Structural changes accumulate across cycles rather than fully resetting.

Follicular stimulation

Regional hyperplasia

Uneven involution

Repeated remodeling

Multiple irregular nodules

Slide 13 · Multinodular goiter is usually a late lesion

The condition may follow a preexisting simple goiter over time.

Recurrent growth and involution require time to produce conspicuous heterogeneity.

Therefore multinodular goiters commonly affect older individuals.

Age association reflects disease evolution, not a distinct single cause.

Longitudinal process

Simple goiter → repeated remodeling → established multinodular goiter

Slide 14 · Sporadic and endemic forms share the phenotype

Multinodular goiters may arise from sporadic or endemic simple goiters.

Sporadic origin

Occurs outside endemic deficiency settings

Can progress from simple goiter

Develops over time

Endemic origin

Related to population iodine deficiency

Can progress from simple goiter

Develops over time

Slide 15 · Follicular cells differ in growth responsiveness

Regional growth differences may arise from unequal responses to trophic stimuli.

Follicular cells need not respond identically to the same systemic signal.

A relatively growth-advantaged population can expand locally.

This mechanism is presented by Robbins as a proposed model.

Shared trophic stimulus

Variable cellular responsiveness

Localized growth advantage

Nodule formation

Slide 16 · The gland contains distinct cellular populations

Polyclonal and monoclonal nodules can coexist within one multinodular goiter.

Polyclonal nodule

Multiple contributing cell lineages

Heterogeneous response to stimuli

Part of multinodular remodeling

Monoclonal nodule

Growth-advantaged lineage

May carry acquired alterations

Can coexist with polyclonal nodules

Slide 17 · Acquired growth advantage is a hypothesis

Some nodules may expand because of somatic genetic abnormalities.

The model is analogous to growth selection in thyroid adenomas.

A clone may become more responsive or partly independent of trophic control.

Not every nodule is proven to follow the same molecular route.

Mechanistic uncertainty

Clonal selection is plausible for some nodules; It is not a universal demonstrated cause.

Slide 18 · TSH-signaling alterations occur in some nodules

Activating molecular changes can underlie follicular autonomy.

TSH-receptor pathway mutations in a subset of autonomous nodules.

The adjacent adenoma section names TSHR and GNAS as components of this pathway.

Pathway activation can uncouple hormone production from normal TSH dependence.

TSH receptor signaling

Follicular-cell activation

Hormone production and/or growth

Autonomous nodules: Activating alterations in a subset

Slide 19 · Growth autonomy and hormone autonomy differ

A large nodule is not automatically hormone producing.

Growth advantage

Local expansion dominates

May contribute to nodularity

No automatic thyrotoxicosis

Hormone autonomy

TSH-independent hormone output

May yield a hot nodule

Can cause toxic disease

Slide 20 · Integrating the pathogenesis

The established phenotype combines repeated remodeling with biological heterogeneity.

Systemic stimulus may initiate or sustain follicular proliferation.

Local differences in responsiveness shape nonuniform nodularity.

Selected autonomous nodules may alter thyroid function in some patients.

Compensatory growth background

Uneven follicular response

Repeated hyperplasia / involution

Clonal selection in some nodules

Morphologic and functional heterogeneity

Slide 21 · Gross phenotype: Multilobulated enlargement

Multinodular goiter is a markedly irregular, asymmetric gland.

Multiple lobules replace a smooth symmetric contour.

Expansion need not be equivalent in the two lobes.

A cross-sectional view may reveal nodules of very different dimensions.

Trachea

Schematic

Slide 22 · Extreme enlargement is possible

Among thyroid disorders, multinodular goiter can produce very large glands.

Glands exceeding 2000 g in extreme examples.

Size contributes to distortion and compression of adjacent structures.

Weight is a description of potential magnitude—not a diagnostic cutoff.

> 2000 g

Reported possible extreme gland weight in the source; Not a routine threshold or expectation.

Slide 23 · Asymmetry explains the distorted neck contour

One lobe can expand substantially more than the opposite lobe.

Gland growth is unpredictable in extent and direction.

An asymmetric thyroid can displace midline structures.

Symmetry should not be assumed from a single palpable dominant swelling.

Trachea

Schematic

Slide 24 · Multiple nodules produce heterogeneous texture

Irregular nodules can differ in size, colloid content and degenerative change.

A nodule-rich gland is not a collection of identical lesions.

Adjacent lesions may show different phases of the growth–involution cycle.

The overall architecture is more informative than a single nodule.

Trachea

Schematic

Slide 25 · Tracheal compression is an anatomic consequence

Large asymmetric goiters may exert pressure on the airway.

Growth occurs near central cervical structures.

Compression may produce respiratory obstruction.

The site and direction of growth are clinically important, not size alone.

Airway

Schematic — spatial relationships simplified

Slide 26 · Esophageal compression accounts for dysphagia

Posterior or deep expansion can impinge on the swallowing pathway.

Enlarged thyroid lobes may extend toward the esophagus.

Dysphagia is a structural mass-effect symptom.

Symptom assessment complements morphologic evaluation.

Simplified axial relationship — anterior above

Trachea

Thyroid lobes

Esophagus

Slide 27 · Intrathoracic extension creates a substernal goiter

Some multinodular glands extend behind the sternum and clavicles.

A substantial component may not be apparent on superficial inspection.

The enlarged gland can occupy the upper thoracic inlet.

The distribution helps explain deeper compressive manifestations.

Progressive gland enlargement

Growth below cervical boundaries

Substernal / intrathoracic extension

Thoracic inlet mass effect

Slide 28 · Retrodeep growth can obscure the full extent

The gland may enlarge behind the trachea or esophagus.

A relatively modest anterior prominence need not reflect the entire lesion.

Deep extensions may alter airway or swallowing relationships.

Anatomic assessment is important when symptoms exceed visible neck findings.

Airway

Schematic — spatial relationships simplified

Slide 29 · A dominant nodule can simulate a tumor

One prominent nodule may be clinically perceived as a solitary thyroid lesion.

The remaining gland can still contain multiple nodules.

A dominant nodule is not synonymous with follicular adenoma.

This distinction matters for histologic and imaging interpretation.

Trachea

Schematic

Slide 30 · Cut surface: Colloid-rich, gelatinous nodules

Irregular nodules contain variable amounts of brown gelatinous colloid.

Colloid imparts a translucent or glistening quality to some nodules.

The macroscopic appearance varies from region to region.

These are source-described gross features, illustrated schematically here.

Trachea

Schematic

Slide 31 · Hemorrhage is a common regressive change

Older multinodular lesions may contain focal bleeding.

Recurrent growth imposes physical stress on the expanded gland.

Hemorrhagic areas can coexist with colloid-rich nodules.

The finding contributes to gross heterogeneity rather than defining a separate tumor.

Hemorrhage

A regressive feature in an established multinodular gland; Interpret in the overall architecture.

Slide 32 · Fibrosis records long-standing remodeling

Fibrotic change is among the degenerative alterations of older nodules.

The gland is altered by cumulative tissue stresses.

Fibrosis can partition areas without forming a continuous adenoma-type capsule.

This distinction prevents overcalling a discrete tumor from scar tissue alone.

Fibrosis ≠ tumor capsule

Nodular goiter lacks a prominent uniform capsule separating all nodules from residual thyroid.

Slide 33 · Calcification and cystic change add complexity

Degeneration can produce calcified and cystically altered regions.

Calcific change

Degenerative mineral deposition

May accompany older lesions

Part of the mixed gross appearance

Cystic change

Focal fluid-filled degeneration

May accompany older lesions

Part of the mixed gross appearance

Slide 34 · The whole gross pattern reflects repeated injury

Colloid accumulation and secondary changes build a patchwork appearance.

Nodular hyperplasia and involution create the baseline architecture.

Hemorrhage, fibrosis, calcification and cysts superimpose additional variation.

No single cut-surface texture characterizes every region.

Repeated nodular remodeling

Variable colloid accumulation

Hemorrhage and fibrosis

Calcification and cystic change

Variegated enlarged gland

Slide 35 · Microscopy shows a follicular mosaic

Large colloid-filled follicles and hyperplastic foci often occur in the same gland.

The microscopic field changes according to the region sampled.

Follicular caliber varies conspicuously.

The collective pattern is more diagnostic than one isolated follicle.

Illustrative follicle patterns — schematic

Slide 36 · Colloid-rich follicles dominate involuted areas

Enlarged lumens contain abundant stored eosinophilic colloid.

The abundant colloid reflects storage rather than a requirement for active secretion.

Large follicles often display relatively inactive lining cells.

Interpret the schematic as an architectural explanation, not a micrograph.

Illustrative follicle patterns — schematic

Slide 37 · Flattened follicular epithelium indicates involution

Epithelium can become attenuated when trophic activity declines.

Flattened cells line distended colloid-rich follicles.

Cell height is a useful morphologic clue to local activation.

A single gland may show different levels of epithelial activity.

Illustrative follicle patterns — schematic

Slide 38 · Hyperplastic follicular foci remain interspersed

Not all follicles undergo identical involution.

Foci of follicular proliferation persist alongside more inactive regions.

Crowded cells contrast with nearby colloid-distended follicles.

A multifocal rather than uniformly hyperplastic pattern is characteristic.

Illustrative follicle patterns — schematic

Slide 39 · The microscopically mixed pattern has a cause

Regional proliferative and involutional histories differ.

Variable cellular responsiveness creates distinct growth trajectories.

Repeated episodes expose individual nodules to nonuniform tissue stress.

Thus the histology recapitulates the disease pathogenesis.

Unequal local growth response

Repeated asynchronous remodeling

Coexisting colloid-rich and hyperplastic foci

Slide 40 · Degenerative changes have histologic correlates

Old lesions may show hemorrhage, scar, calcification and cyst formation.

Follicular changes

Colloid-rich lumens

Flattened lining epithelium

Intermixed hyperplastic foci

Regressive changes

Hemorrhage

Fibrosis and calcification

Cystic degeneration

Slide 41 · Absence of a discrete capsule is important

Prominent encapsulation between nodules and residual parenchyma is not a defining feature.

Multiple nodules blend into a remodeled gland.

Residual thyroid may be compressed without a continuous tumor capsule.

This architecture helps distinguish follicular nodular disease from many adenomas.

Trachea

Schematic

Slide 42 · Follicular nodular disease: The histologic term

This designation emphasizes the overall benign follicular remodeling pattern.

The clinical phrase multinodular goiter describes the gland-level appearance.

The histologic label highlights nonuniform follicles, colloid and secondary change.

Terminology avoids automatically labeling each nodule a separate neoplasm.

Clinical ↔ histologic

Multinodular goiter ↔ follicular nodular disease

Slide 43 · Diffuse versus multinodular goiter

The distinction is mainly the evolution from symmetric to irregular architecture.

Diffuse simple goiter

Relatively symmetric enlargement

Hyperplastic and colloid phases

Often less extreme growth

Multinodular goiter

Asymmetric nodular enlargement

Mixed activity and degeneration

Potentially extreme growth

Slide 44 · Multinodular goiter versus follicular adenoma

The presence of multiple nodules and lack of a consistent capsule favor follicular nodular disease.

Follicular nodular disease

Multiple variably sized nodules

No prominent uniform capsule

Heterogeneous follicular patterns

Follicular adenoma

Usually solitary lesion

Typically sharply circumscribed

Often a well-defined capsule

Slide 45 · Clinical manifestations are mainly compressive

Gland volume and location explain much of the clinical presentation.

Cosmetic enlargement can be the initial concern.

Tracheal, esophageal and vascular compression can dominate symptoms.

Functional hyperthyroidism is a distinct possibility in some patients.

Airway

Schematic — spatial relationships simplified

Slide 46 · Visible swelling is a consequence, not a diagnosis

Neck contour changes reflect enlarged thyroid tissue.

Multilobulated nodules may produce an irregular visible mass.

Cosmetic prominence does not reliably indicate hormone output.

A visible dominant prominence does not establish that the nodule is neoplastic.

Trachea

Schematic

Slide 47 · Airway obstruction requires recognition

Large goiters may physically narrow the airway.

Tracheal compression may arise from lateral or deep gland growth.

Respiratory complaints should be interpreted in relation to gland extent.

Airway obstruction as a major mass effect.

Airway

Schematic — spatial relationships simplified

Slide 48 · Dysphagia localizes the mass effect

The enlarged thyroid can compromise adjacent swallowing structures.

Esophageal compression explains the symptom mechanistically.

Deep or retrotracheal extension makes location clinically relevant.

This symptom does not itself establish malignancy.

Simplified axial relationship — anterior above

Trachea

Thyroid lobes

Esophagus

Slide 49 · Vascular compression can be consequential

A large cervical or intrathoracic gland can compress major neck and upper-thoracic veins.

Superior vena cava syndrome as a possible complication.

Thoracic extension can alter the relationship to major vessels.

The vascular manifestation reflects a space-occupying effect.

Major vessel

Schematic — spatial relationships simplified

Slide 50 · Most multinodular goiters are euthyroid

Normal hormone status is common despite substantial gland enlargement.

Compensatory thyroid growth may maintain hormone supply.

Mass effects can therefore predominate without thyrotoxicosis.

Function needs clinical and biochemical correlation.

Common pattern

Enlarged, multinodular gland with preserved thyroid function.

Slide 51 · Toxic multinodular goiter: Plummer disease

Autonomous functioning regions may produce hyperthyroidism.

Overactive nodules need not depend on ordinary TSH stimulation.

The gland may simultaneously contain less active nodules.

Toxic disease is a functional subset, not the definition of all multinodular goiters.

TSH receptor signaling

Follicular-cell activation

Hormone production and/or growth

Autonomous nodules: Activating alterations in a subset

Slide 52 · Radioiodine uptake is heterogeneous

A multinodular gland may contain both high-uptake and low-uptake areas.

Autonomous hot nodules exhibit increased radionuclide uptake.

Nonfunctioning cold nodules show comparatively reduced uptake.

The scan pattern reflects functional heterogeneity, not automatically malignancy.

Illustrative uptake pattern

HOT

COLD

HOT

COLD

Conceptual scan schematic — not a patient scan

Slide 53 · Hot and cold nodules answer different questions

Radionuclide behavior addresses function; It is not a complete tissue diagnosis.

Hot nodule

Higher radioactive iodine uptake

Often autonomous functional activity

Generally more likely benign

Cold nodule

Lower radioactive iodine uptake

Nonfunctioning tissue region

May warrant suspicious-nodule workup

Slide 54 · Malignancy risk is low but not absent

Carcinomas can occur within a multinodular gland.

Low malignancy incidence in long-standing multinodular goiter.

A background diagnosis of goiter does not exempt a suspicious nodule.

Assessment is guided by concerning features, not the goiter label alone.

Low risk ≠ zero risk

A suspicious focal nodule requires assessment despite an otherwise benign multinodular background.

Slide 55 · Sudden changes and hoarseness warrant concern

Changes in the clinical course can signal a process requiring separate assessment.

Sudden changes in size or symptoms.

New hoarseness is an example of a concerning symptom.

These findings are warning signs rather than proof of carcinoma.

Clinical warning

Sudden enlargement, altered symptoms or hoarseness: Reassess for a suspicious lesion.

Slide 56 · Suspicious ultrasound features modify evaluation

Focal sonographic abnormalities help select nodules for further assessment.

Background goiter

Multiple nodules can be benign

Overall architecture heterogeneous

Many patients euthyroid

Suspicious focus

Concerning sonographic morphology

Possible clinical change

Targeted diagnostic consideration

Slide 57 · Fine-needle aspiration may clarify selected nodules

Aspirating selected cold or suspicious nodules can help identify neoplasia.

The source describes FNA as helpful for evaluation of cold nodules.

Cytology distinguishes benign and malignant processes in many—but not all—cases.

Indeterminate results may require additional assessment.

Identify clinically / sonographically concerning nodule

Review functional imaging when relevant

Consider targeted FNA

Interpret cytology with limitations

Slide 58 · No single finding resolves every thyroid nodule

A nodule may look dominant, appear cold or yield indeterminate cytology.

What each test contributes

Symptoms: Mass effects and change

Ultrasound: Nodule morphology

FNA: Sampled cellular features

What it cannot guarantee

Clinical examination: Not histology

Imaging: Not definitive cancer diagnosis

Cytology: Sometimes indeterminate

Slide 59 · Morphologic synthesis: Diagnose the whole gland

Pathology interpretation combines nodules, adjacent thyroid and regressive changes.

Document multinodular architecture and follicular heterogeneity.

Correlate colloid-rich follicles, hyperplasia and degenerative changes.

Examine any discrete suspicious focus separately from background nodular disease.

Trachea

Schematic

Slide 60 · Case 1: An enlarging gland with dysphagia

An older patient has a long-standing irregular neck mass and increasing swallowing difficulty.

Discuss

Which anatomic mechanism best explains the symptom?

What gross pattern would support multinodular goiter?

Does dysphagia alone establish a malignant lesion?

Interpretation

Esophageal compression from a multilobulated enlarged gland explains dysphagia. An asymmetric gland with variably sized colloid-rich nodules supports multinodular goiter. Dysphagia alone is not proof of cancer.

Slide 61 · Case 2: Functional heterogeneity

A multinodular gland shows uneven radioiodine uptake with both hot and cold foci.

Discuss

What explains a functional hot focus?

Would every nodule need the same hormone output?

What additional issue arises with a suspicious cold focus?

Interpretation

An autonomously functioning focus can increase uptake and hormone secretion. Functional states vary across nodules. A suspicious cold nodule should be evaluated on its own merits, including targeted sampling when indicated.

Slide 62 · Case 3: A prominent solitary-appearing nodule

A clinically dominant nodule is found in an irregular thyroid with additional small nodules.

Discuss

Which findings favor follicular nodular disease over adenoma?

Why is attention to the surrounding gland essential?

What would raise concern for a coexisting neoplasm?

Interpretation

Multiple background nodules, variable follicles and no uniform capsule favor follicular nodular disease. Concerning ultrasound features, rapid change or new hoarseness require further assessment.

Slide 63 · Diagnostic contrasts worth retaining

Interpret functional, gross and microscopic evidence as complementary—not interchangeable.

Structure

Asymmetric multinodularity

Variable follicles

No uniform capsule

Function

Usually euthyroid

Sometimes autonomous hot foci

Toxic subset possible

Focal risk

Suspicious ultrasound

Clinical warning signs

Targeted evaluation

Slide 64 · Five linked conclusions

The core diagnostic model integrates the long-standing process and its consequences.

Repeated follicular hyperplasia and involution create irregular nodules.

Mixed polyclonal and monoclonal nodules, with autonomy in some, explain heterogeneity.

Gross colloid-rich and degenerative changes mirror the microscopic mosaic.

Compressive effects dominate; Most patients remain euthyroid.

Suspicious nodules must be investigated despite low overall cancer risk.

Slide 65 · Textbook source and verification boundary

Primary reference used throughout this presentation.

Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th ed. (2026).

Chapter 24, The Endocrine System; Diffuse and Multinodular Goiter, pp. 985–987.

Adjacent Neoplasms of the Thyroid / Thyroid Adenomas: contextual comparison, pp. 987–988.

Supplied Markdown conversion used; original chapter PDF and textbook figures were unavailable for image-level comparison.